+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Hemoglobin Testing Market 2018-2022 - Product Image

Global Hemoglobin Testing Market 2018-2022

  • ID: 4613301
  • Report
  • August 2018
  • Region: Global
  • 133 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Bio-Rad Laboratories
  • Danahar
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • MORE
About Hemoglobin Testing

Hemoglobin testing is carried out to check the level of the red blood cells in the blood. This test is part of routine checkup and aids in diagnosing conditions or diseases such as anemia, diabetes, leukemia, chronic kidney disease, and hypothyroidism.
The analysts forecast the Global Hemoglobin Testing Market to grow at a CAGR of 8.14% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the hemoglobin testing market. To calculate the market size, the report considers the revenue generated from the retail sales of hemoglobin testing products, including instruments and consumables, and services across the globe.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, hemoglobin testing market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott, Bio-Rad Laboratories
  • Danahar
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific
Market drivers
  • Growing incidence of diabetes worldwide
  • For a full, detailed list, view the full report
Market challenges
  • Limitations of hemoglobin testing
  • For a full, detailed list, view the full report
Market trends
  • Growing preference for home care settings
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Bio-Rad Laboratories
  • Danahar
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER
  • Segmentation by end-user
  • Comparison by end-user
  • Healthcare centers – Market size and forecast 2017-2022
  • Diagnostic laboratories – Market size and forecast 2017-2022
  • Others – Market size and forecast 2017-2022
  • Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast 2017-2022
  • EMEA – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Growing preference for home care settings
  • Increasing use of POCT
  • Availability of advanced testing devices
  • Rise in elderly population
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific
PART 15: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Global laboratory equipment market
Exhibit 02: Global laboratory equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global hemoglobin testing market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global hemoglobin testing market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Customer landscape
Exhibit 19: End-user – Market share 2017-2022 (%)
Exhibit 20: Comparison by end-user
Exhibit 21: Healthcare centers – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Healthcare centers – Year-over-year growth 2018-2022 (%)
Exhibit 23: Diagnostic laboratories – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Diagnostic laboratories – Year-over-year growth 2018-2022 (%)
Exhibit 25: Others – Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Others – Year-over-year growth 2018-2022 (%)
Exhibit 27: Market opportunity by end-user
Exhibit 28: Global hemoglobin testing market – Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 37: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: R&D funding in diabetes 2015-2016 ($ millions)
Exhibit 41: Rise in the population aged 65 and above (% of total)
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendor
Exhibit 47: Abbott – Overview
Exhibit 48: Abbott – Business segments
Exhibit 49: Abbott – Organizational developments
Exhibit 50: Abbott – Geographic focus
Exhibit 51: Abbott – Segment focus
Exhibit 52: Abbott – Key offerings
Exhibit 53: Bio-Rad Laboratories – Overview
Exhibit 54: Bio-Rad Laboratories – Business segments
Exhibit 55: Bio-Rad Laboratories – Organizational developments
Exhibit 56: Bio-Rad Laboratories – Geographic focus
Exhibit 57: Bio-Rad Laboratories – Segment focus
Exhibit 58: Bio-Rad Laboratories – Key offerings
Exhibit 59: Danaher – Overview
Exhibit 60: Danaher – Business segments
Exhibit 61: Danaher – Organizational developments
Exhibit 62: Danaher – Geographic focus
Exhibit 63: Danaher – Segment focus
Exhibit 64: Danaher – Key offerings
Exhibit 65: EKF Diagnostics – Overview
Exhibit 66: EKF Diagnostics – Business segments
Exhibit 67: EKF Diagnostics – Organizational developments
Exhibit 68: EKF Diagnostics – Geographic focus
Exhibit 69: EKF Diagnostics – Segment focus
Exhibit 70: EKF Diagnostics – Key offerings
Exhibit 71: F. Hoffmann-La Roche – Overview
Exhibit 72: F. Hoffmann-La Roche – Business segments
Exhibit 73: F. Hoffmann-La Roche – Organizational developments
Exhibit 74: F. Hoffmann-La Roche – Geographic focus
Exhibit 75: F. Hoffmann-La Roche – Segment focus
Exhibit 76: F. Hoffmann-La Roche – Key offerings
Exhibit 77: Siemens Healthineers – Overview
Exhibit 78: Siemens Healthineers – Business segments
Exhibit 79: Siemens Healthineers – Organizational developments
Exhibit 80: Siemens Healthineers – Geographic focus
Exhibit 81: Siemens Healthineers – Segment focus
Exhibit 82: Siemens Healthineers – Key offerings
Exhibit 83: Thermo Fisher Scientific – Overview
Exhibit 84: Thermo Fisher Scientific – Business segments
Exhibit 85: Thermo Fisher Scientific – Organizational developments
Exhibit 86: Thermo Fisher Scientific – Geographic focus
Exhibit 87: Thermo Fisher Scientific – Segment focus
Exhibit 88: Thermo Fisher Scientific – Key offerings
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott
  • Bio-Rad Laboratories
  • Danahar
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • MORE
New Report Released: - Global Hemoglobin Testing Market 2018-2022

The author of the report recognizes the following companies as the key players in the global hemoglobin testing market: Abbott, Bio-Rad Laboratories, Danahar, EKF Diagnostics, F. Hoffmann-La Roche, Siemens Healthineers, and Thermo Fisher Scientific.

Commenting on the report, an analyst from the research team said: “One trend affecting this market is the growing preference for home care settings. Blood hemoglobin is a common method of detecting blood glucose levels and anemia in both acute care and outpatient settings.”

According to the report, one driver influencing this market is the growing incidence of diabetes worldwide. The diabetes epidemic is spreading worldwide which is creating huge demand for effective and advanced hemoglobin testing devices to monitor blood glucose levels.

Further, the report states that one challenge affecting this market is the limitations of hemoglobin testing. Blood hemoglobin is the common indicator for diagnosing conditions like anemia, and diabetes, which is often determined by analyzing the blood sample of patients.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott
  • Bio-Rad Laboratories
  • Danahar
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll